Multiple Sclerosis Society of Canada

Centre for Drug Research and Development (CDRD)

The Multiple Sclerosis Society of Canada and the Centre for Drug Research and Development (CDRD) are partners with the aim of accelerating preclinical development of novel therapies for MS. To achieve this goal, the organizations seek to fund collaborative projects aimed at developing new disease-modifying therapies for progressive MS.

____________________________________________________________________

Request for Pre-Proposals for Collaborative Projects to Discover and Develop New Treatments for Progressive Multiple Sclerosis


CDRD and the Multiple Sclerosis Society of Canada are continuing their partnership aimed at accelerating preclinical development of novel therapies for multiple sclerosis. To achieve this goal, the organizations are seeking pre-proposals from investigators who are working on research projects aimed at developing new disease-modifying therapies for progressive MS. Such therapies may include novel approaches to promote remyelination, repair existing damage and/or protecting neurons to positively impact the progressive forms of the disease.

Click here to access the full Request for Pre-Proposals.